Satoris to Distribute RBM's Biomarker Panel for Neuro Research | GenomeWeb

NEW YORK (GenomeWeb News) – Molecular diagnostics firm Satoris today said that it has been appointed global distributor for Rules-Based Medicine's DiscoveryMAP panel for neurology research.

The RBM DisocveryMAP is a 189-biomarker panel that covers the most physiologically relevant pathways and includes biomarkers known to be important in the major disease processes for drug development, said Redwood City, Calif.-based Satoris in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.